Related Experiment Video
Updated: Jan 25, 2026

Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs
Published on: April 14, 2015
A TaqMan Probe-Based Real-Time PCR Assay for the Rapid Identification of the Emerging Multidrug-Resistant Pathogen
Amorce Lima1, Raymond Widen2, Grant Vestal2
1Esoteric Testing/R&D Laboratory, Tampa General Hospital, Tampa, Florida, USA alima@tgh.org.
Abstract:
Candida auris is an emerging multidrug-resistant fungal pathogen that has been associated with nosocomial bloodstream and deep wound infections causing a high mortality rate mainly in intensive care unit (ICU) patients. Laboratories currently rely on phenotypic testing using commercial automated systems for identification of yeasts; however, this technique has often led to misidentification of C. auris to other closely related species. We developed and validated a TaqMan-based real-time PCR assay on the BD Max platform targeting ribosomal DNA (rDNA) region nucleotide sequences to quickly and accurately test for C. auris infection from culture and clinical specimens. The assay is highly specific, reproducible, and sensitive, allowing detection of as low as 1 C. auris CFU per reaction within 3 h.
Insights
A new real-time PCR assay accurately identifies Candida auris, a dangerous multidrug-resistant fungus. This rapid diagnostic tool helps prevent misidentification and improves patient care in intensive care units (ICUs).
Area of Science:
- Clinical Microbiology
- Molecular Diagnostics
- Infectious Diseases
Background:
- Candida auris is an emerging, multidrug-resistant fungal pathogen causing severe nosocomial infections, particularly in intensive care unit (ICU) patients.
- Current yeast identification methods, relying on phenotypic testing, frequently misidentify C. auris, hindering timely and appropriate treatment.
- Accurate and rapid diagnostics are crucial for managing C. auris outbreaks and improving patient outcomes.
Purpose of the Study:
- To develop and validate a novel TaqMan-based real-time PCR assay for the accurate and rapid detection of Candida auris.
- To evaluate the assay's performance on the BD Max platform using both cultured isolates and direct clinical specimens.
- To provide a reliable diagnostic tool to overcome the limitations of current phenotypic identification methods.
Main Methods:
- Development of a TaqMan-based real-time PCR assay targeting the ribosomal DNA (rDNA) region of Candida auris.
- Validation of the assay on the BD Max automated platform.
- Testing of the assay's sensitivity, specificity, and reproducibility using various samples, including clinical specimens.
Main Results:
- The developed real-time PCR assay demonstrated high specificity and reproducibility.
- The assay achieved a high level of sensitivity, detecting as few as 1 Candida auris Colony Forming Unit (CFU) per reaction.
- The diagnostic test provided accurate identification of C. auris within 3 hours.
Conclusions:
- The validated TaqMan-based real-time PCR assay offers a rapid, accurate, and reliable method for identifying Candida auris.
- This molecular diagnostic approach effectively addresses the misidentification issues associated with conventional phenotypic methods.
- The assay has the potential to significantly improve the management of C. auris infections in healthcare settings.
Related Concept Videos
Real Time RT-PCR
The real-time quantification of the number of amplified products is...
Emerging Adulthood
PCR
Introduction Cardiac Emergencies
Resistivity
Resistance

